Insider Transactions and Holdings
-
Entity Type
-
Individual
-
Role
-
VP/Chief Accounting Officer
-
Stock Symbol
-
APLS on Nasdaq
James Chopas - trading volume in the past year for Apellis Pharmaceuticals, Inc.
Class |
Num Shares |
Value |
Price $ |
Transaction Date |
Ownership |
Underlying Class |
Underlying Amount |
Common Stock |
38.1K |
$1.38M |
$36.21 |
Sep 16, 2024 |
Direct |
|
|
Stock Option (Right to Buy) |
12.1K |
$801K |
$66.30 |
Jan 16, 2024 |
Direct |
Common Stock |
|
Sym |
Class |
Transaction |
% |
Value $ |
* Price $ |
Shares |
Shares After |
Date |
Ownership |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.